Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 14, 2018 - Issue 11
Submit an article Journal homepage
550
Views
0
CrossRef citations to date
0
Altmetric
Reply Letter

Reply letter to “Fatal meningococcemia due to Neisseria meningitidis serogroup Y in a vaccinated child receiving eculizumab”

Alexandra W. DretlerEmory University School of Medicine, Atlanta, GA, USA
,
Nadine G. RouphaelEmory University School of Medicine, Atlanta, GA, USA
&
David S. StephensEmory University, Atlanta, GA, USACorrespondence[email protected]
Pages 2803-2804 | Published online: 16 Jul 2018

References

  • Polat M, Yüksel S, Şahin NÜ. Fatal meningococcemia due to Neisseria meningitidis serogroup Y in a vaccinated child receiving eculizumab. Hum Vaccin Immunother., 1-1.
  • Food and Drug Administration. Soliris product insert. In: US Department of health and human services food and drug administration. Silver Spring, MD., 2017.
  • McNamara LA, Topaz N, Wang X, Hariri S, Fox L, MacNeil JR. High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine. MMWR Morbidity and Mortality Weekly Report. 2017;66:734–7. doi:10.15585/mmwr.mm6627e1. PMID:28704351.
  • Cohn AC, MacNeil JR, Clark TA, Ortega-Sanchez IR, Briere EZ, Meissner HC, Baker CJ, Messonnier NE, Centers for Disease Control and Prevention (CDC). Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morbidity and Mortality Weekly Report. 2013;62:1–28. PMID:23302815.
  • Folaranmi T, Rubin L, Martin SW, Patel M, MacNeil JR. Use of Serogroup B Meningococcal Vaccines in Persons Aged >/ = 10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015. MMWR Morbidity and Mortality Weekly Report. 2015;64:608–12.
  • Parikh SR, Lucidarme J, Bingham C, Warwicker P, Goodship T, Borrow R, Ladhani SN. Meningococcal B vaccine failure with a penicillin-resistant strain in a young adult on long-term eculizumab. Pediatrics. 2017;140(3). doi:10.1542/peds.2016-2452.
  • Konar M, Granoff DM. Eculizumab treatment and impaired opsonophagocytic killing of meningococci by whole blood from immunized adults. Blood. 2017 Aug 17;130(7):891–9. doi:10.1182/blood-2017-05-781450.
  • Cullinan N, Gorman KM, Riordan M, Waldron M, Goodship TH, Awan A. Case report: benefits and challenges of long-term eculizumab in atypical hemolytic uremic syndrome. Pediatrics. 2015;135(6). doi:10.1542/peds.2014-3503. PMID:25941307.
  • Kaplon H, Reichert JM. Antibodies to watch in 2018. mAbs. 2018;10(2):183–203. doi:10.1080/19420862.2018.1415671. PMID:29300693.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.